[ALNY] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
04-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -13.51%
YoY- -102.80%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 33,294 21,899 18,960 7,345 18,537 8,275 18,642 10.14%
PBT -181,220 -141,276 -107,290 -102,974 -51,208 -268,813 -9,575 63.21%
Tax 695 -62 -2,128 -6,414 -431 -17,870 -562 -
NP -181,915 -141,214 -107,290 -102,974 -50,777 -250,943 -9,013 64.96%
Tax Rate - - - - - - - -
Total Cost 215,209 163,113 126,250 110,319 69,314 259,218 27,655 40.74%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -546.39 -644.84 -565.88 -1,401.96 -273.92 -3,032.54 -48.35 49.77%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -1.73 -1.41 -1.25 -1.21 -0.62 -3.70 -0.15 50.28%
EPS Diluted -1.73 -1.41 -1.25 -1.21 -0.62 -3.70 -0.15 50.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.